NDRA

Stats

Summary

endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we’re proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.

Market Cap: 12.4 Million

Primary Exchange: NASDAQ

Website:

Shares Outstanding: 11 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.47089445313661293

Sector: Manufacturing

Industry: Electromedical and Electrotherapeutic Apparatus Manufacturing

Ethical Flags

Longest drawdown: 1270 trading days

From: 2018-10-30 To: 2022-12-20

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor